HER2-targeted therapy
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for HER2-targeted therapy, covering 2025-08-03 to 2026-04-27. Get the full timeline:
Most recent: Clinical Trial Update: Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast Cancer [Phase 3]